Lungpacer Medical, Inc.
StreetZero Signal 68
About Lungpacer Medical, Inc.
Lungpacer Medical, Inc. is a privately held medical device company focused on improving respiratory and critical care medicine. Headquartered in Vancouver, Canada, with US offices in Exton, Pennsylvania, it designs non-surgical, minimally invasive technologies to ventilate patients more safely and effectively. The Lungpacer Diaphragm Pacing Therapy System is the first minimally invasive, temporary transvenous diaphragmatic neurostimulation system. The company was incorporated on May 27, 2009.
LATEST FUNDINGPrivate Placement
$12.0M
Announced 2026-10-08
TOTAL RAISED$137M
IN THE NEWS
- 🔗 Lungpacer - 2026 Company Profile, Funding & Competitors - Tracxn
- 🔗 Lungpacer Medical - Products, Competitors, Financials, Employees, Headquarters Locations
- 🔗 Lungpacer 2026 Company Profile: Valuation, Funding & Investors | PitchBook
- 🔗 Lungpacer Medical Stock Price, Funding, Valuation, Revenue & Financial Statements
- 🔗 Lungpacer Medical
EMPLOYEES—
FOUNDED2009
HQExton, PA, United States
Industry
Other Health Care
Tags
Medical DeviceNeurostimulationRespiratory CareDiaphragm Pacing
Key highlights
- Raised $12M via convertible note in latest round reported as private placement.
- Total funding exceeds $133M across 8-9 rounds since 2013.
- Backed by 8+ institutional investors including NEA and KCK.
- Developing first minimally invasive temporary transvenous diaphragmatic neurostimulation system.
- Operates with offices in Vancouver, Canada and Exton, Pennsylvania.
Ask StreetZero about Lungpacer Medical, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account